Araclon Biotech
|
Year Established:
2004 |
|
|
Website:
araclon.com |
|
|
Company Type:
Large Business (>100M TTM Revenue) |
Araclon Biotech is a small company founded in 2004 dedicated to the research and development of therapies and diagnostic methods for Alzheimer’s disease. Even though being a small company, Araclon is part of Grifols, being the major shareholder, so it has been classified as a large business.
Currently we offer the quantification of Alzheimer’s Disease relevant Aβ42 and Aβ40 peptides in plasma by two proprietary methods: ELISA and Liquid-Chromatography-Mass Spectrometry assays. These assays are carried out as a service at our facilities in Spain and US.
| Site | Badges | |
|---|---|---|
| Araclon Biotech Vía Hispanidad, 21 (edificio Araclon) Zaragoza, Zaragoza, 50009 Spain | ||
Get started
If your organization has a Scientist.com marketplace, you can log in here to order products and services directly. If you're interested in ordering custom research services from suppliers in the Scientist.com network, book a meeting with our team here. To order products instantly, request access below.